Treatment success despite antibiotic resistance in Helicobacter pylori isolated in Malmö, Sweden;Antibiotikaresistens hos Helicobacter pylori i Malmö: Behandlingsframgång trots antibiotikaresistens

Lakartidningen

Volumn 96, Issue 5, 1999, Pages 460-463

  Nilsson, Folke ^a,c   Walder, Mats ^b  

^a Lakarhuset Ellenbogen   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Ellenbogen Medical Centre   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIULCER AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ANTIBIOTIC RESISTANCE; DRUG COMBINATION; DRUG EFFECT; DUODENUM ULCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; STOMACH ULCER; SWEDEN;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; DUODENAL ULCER; GUIDELINES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; OMEPRAZOLE; PATIENT EDUCATION; STOMACH ULCER; SWEDEN;

EID: 0033518448     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Norrby R. Behandling av H pylori kan ge skräckscenario. Läkartidningen 1996; 93: 4267-8.
2. Sjölund K, Engstrand L. H pylori - världens vanligaste infektion. Behandla på rätt indikation! Läkartidningen 1997; 94: 2909-10.
3. Jaup B, Brandberq A, Stenquist B, Norrby A. Antibiotikaresistens hos stammar av Helicobacter pylori i Göteborg. Bakterierna resistenta mot metronidazol. Läkartidningen 1998; 95: 279-81.
4. Rautelin H, Seppala K, Nuutinen H, Karkkainen P, Sipponen P, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163-6.
5. Lerang F, Mourn B, Haug JB, Berge T, Tolas P, Sandvei PK et al. Highly effective twice-daily triple therapies of Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 1997; 92: 248-53.
6. Peitz U, Nusch A, Tillenburg B, Becker T, Stolte M, Börsch G et al. Frequent metronidazole resistance without significant impact on the high cure rate of H pylori by triple therapy with omeprazole, metronidazole and clarithromycin. Gastroenterology 1996; 110: 226A.
7. Raymond J, Kalach N, Bergeret M, Benhamou PH, Barbet JP, Gendrel D et al. Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children. Antimicrobial Agents and Chemotherapy 1998; 42: 1334-5.
8. Soltesz V, Schalén C, Mårdh PA. New selective medium for Campylobacter pylori. In: Proceedings of the forth international workshop of Campylobacter infections. Göteborg: B Kaijser, 1987, abstract No.237: 433-6.
9. Cederbrant G, Kahlmeter G. Ljungh Å. The E test for antimicrobial susceptibility testing of Helicobacter pylori. J Antimicrob Chemother 1993; 31: 65-71.
10. Hirschl AM, Hirschl MM, Rotter ML. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother 1993; 32: 45-9.
11. Meqraud F. Antibiotic resistance in Helicobacter pylori infection. Br Med Bull 1998; 54: 207-16.
12. Hulten K, Jaup B, Stenquist B, Enqstrand L. Combination treatment with ranitidine is highly efficient against Helicobacter pylori despite negative impact of macrolid resistance. Helicobacter 1997; 2: 188-93.